Net sales rose 62% year-over-year in Q2 2025, with MRR up 34% and EBITDA nearly breakeven. Strategic partnerships and a capital raise support continued growth, while management targets positive cash flow in the near term.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.